Tasigna works by blocking certain proteins in the body from activating and growing certain cells. The drug is used to prevent cancer cells from growing because it doesn’t harm healthy non-cancerous cells.
However, because of its effect on white blood cells, the drug has been associated with serious and life-threatening conditions. To find more information about filing a Tasigna lawsuit for atherosclerosis or peripheral arterial disease then you can search various online sources.
One of the most very popular medications issued to take care of this kind of cancer would be Tasigna, also called Nilotinib because its normal form. It’s classified as being a tyrosine kinase inhibitor that’s intended to block a protein, Bcr-Alb. This protein block suppresses the leukemia cells by increasing.
But, Tasigna will be understand to have serious unwanted effects as well: liver inflammation, bleeding from the mind, Tumor Lysis Syndrome, diminished blood circulation, very low blood flow, and QT prolongation that might result in sudden departure.
Current lawsuit of Tasigna highlights a connection between taking the drug using Atherosclerosis. The negative effect isn’t yet recorded or supported by the FDA; nevertheless, lawsuits are now being registered against Tasigna’s fabrication, Novartis.
We’re currently exploring claims of severe injury involving hardening of the lungs and associated illnesses, including carotid artery disease, coronary heart disorder, in addition to peripheral artery disease and also leading amputations. In the event that you or someone you care about suffered these negative effects after undergoing therapy with Tasigna, touch us now.
Novartis along with Health Canada, in Addition to Canada and the Buyer Information Leaflet have upgraded the symptom listing to add Atherosclerosis. Nevertheless, producer has to take favorable actions and also do exactly the exact same for its consumers from the USA.
If you or someone you know was prescribed Tasigna and was diagnosed with Atherosclerosis, you may be entitled to compensation on behalf of the manufacture.